Last updated on August 2018

Moderate to Severe Plaque Psoriasis


Brief description of study

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects with Moderate-to-Severe Plaque Psoriasis.

 

Clinical Study Identifier: TX210462

Contact Investigators or Research Sites near you

Start Over

Diana, Recruitment Specialist

Direct Helpers Research Center
Hialeah, FL USA
  Connect »